SLV-154 Treatment of Advanced Cancers (NCT06771219)
A Phase 1 Dose-Escalation/Expansion Study of SLV-154 in Subjects With Advanced Cancers
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 1 study comprising a Phase 1a dose-escalation portion and a Phase 1b expansion portion evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with advanced solid tumors.
Who can join: Review the eligibility criteria below.
Location: Hoag Memorial Hospital Presbyterian — Newport Beach, California
Age range: 12 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (10 Sites)
- Hoag Memorial Hospital Presbyterian — Newport Beach, California
- Washington University — St Louis, Missouri
- Astera Cancer Care — East Brunswick, New Jersey
- Memorial Sloan Kettering Cancer Center — New York, New York
- University Hospitals Cleveland Medical Center — Cleveland, Ohio
- MD Anderson Cancer Center — Houston, Texas
- Oncology Consultants — Houston, Texas
- Mays Cancer Center; University of Texas Health San Antonio — San Antonio, Texas
- University of Washington / Fred Hutchinson Cancer Center — Seattle, Washington
- Northwest Medical Specialties, PLLC — Tacoma, Washington
📞 Contact the Study Coordinator
Phone: (425) 894-2558
Email: hren@solvetx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Advanced Cancer
- Intrapleural Catheter Daily Versus Three Times a Week Drainage — Houston, Texas
- Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer — Toronto, Ontario
- Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer — New York, New York
- FS120 Phase 1/1b Study in Patients With Advanced Malignancies — New Haven, Connecticut
- First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer — Encinitas, California
- Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) — Santa Rosa, California
Explore by condition: All Advanced Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.